Life-Sciences-Benelux.com
The Benelux Life Sciences Web Portal

This is a free web portal for the life sciences in Belgium, The Netherlands and Luxembourg... » read more

Univercells Secures up to €50m Investment from KKR (2020-02-18)
Univercells, an innovative bioprocessing provider focused on increasing the availability of affordable biologics to address global health challenges, has announced up to EUR 50M financing from Gamma Biosciences, a new investment platform supported by leading global...
OncoDNA Closes €19m Series B Co-led by Vesalius & Swisscanto (2020-02-14)
OncoDNA (“OncoDNA or “the Company”), the healthcare technology company making precision medicine a reality, today announced that it has completed a €19 million ($20 million) Series B equity financing. The new funding will support rapid international growth, acceler...
Azafaros Completes €25m Series A Round, Led by Forbion (2020-02-06)
Financing round led by Forbion with participation from BioMedPartners and founding investor BioGeneration Ventures Azafaros B.V. announced today the successful closing of its Series A financing round raising EUR 25 million (approximately USD 28 million). Thi...
Catalent to Acquire MaSTherCell Global for $315m in Cash (2020-02-03)
Catalent, Inc. (NYSE: CTLT), the leading global provider of advanced delivery technologies, development, and manufacturing solutions for drugs, biologics, gene therapies, and consumer health products, and MaSTherCell Global, Inc., a technology-focused cell and gene...
Catalent Announces Pricing of up to $575m Public Offering (2020-02-03)
Catalent, Inc. (“Catalent”) (NYSE:CTLT), the leading global provider of advanced delivery technologies, development, and manufacturing solutions for drugs, biologics, gene therapies, and consumer health products, today announced the pricing of an underwritten publi...
iTeos Therapeutics: €15m Non-dilutive Funding from Wallonia (2020-01-30)
Funds will be used to progress iTeos’ two highly innovative clinical-stage oncology programs: a best-in class A2A receptor antagonist and an ADCC-enabled anti-TIGIT antibody drug candidate iTeos Therapeutics SA, a privately-held biotechnology company developin...
Galapagos Promotes Michele Manto to Chief Commercial Officer (2020-01-23)
Galapagos is preparing to deliver its first medicine to patients Galapagos NV (Euronext & NASDAQ: GLPG) announced today that Michele Manto was appointed Chief Commercial Officer, effective 1 January 2020. He served as Senior Vice President Commercial Operation...
iOnctura Raises €15m Series A Financing to Enter the Clinic (2020-01-23)
iOnctura B.V., a clinical stage biopharmaceutical company, developing a pipeline of next generation molecules targeting cancer and fibrosis, announces today the closing of a EUR 15 million Series A financing. The financing was led by INKEF Capital and co-led by VI ...
PDC*line Raises €13.9m Series B plus €6.1m in Grants & Loans (2020-01-22)
Funding includes €13.9M in equity and €6.1M in grants; will support company’s phase I/II trial with PDC*lung01 candidate in lung cancer PDC*line Pharma, a clinical stage biotech company developing a new class of potent and scalable active immunotherapies for...
Osteolabs: First Commercial Contracts & Research Agreement (2020-01-20)
New facilities opened by Minister for Economic and Technological Affairs of Schleswig-Holstein osteolabs GmbH today announced the successful closing of its first commercial agreements for Germany and Turkey. For Germany, the company has signed up with Eurofins...

Life-Sciences-Benelux.com is your doorway to the Benelux life sciences!

[LSBNL] provides free, up-to-date and structured access to

– News
– Products
– Persons
– Organisations
– Financings
– Collaborations

in the Benelux countries Belgium, The Netherlands and Luxembourg.

Access is unrestricted and free, requiring no log in and no user registration.The high-quality content is not related to the advertising, with topical relevance being the criterion for inclusion. [LSBNL] is 100% Made in Germany!

Start here with the latest News!

Picture Kentro Design Corporate and Web Design Berlin 650x65px

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)